Emily S Ford1, Camille E Puronen, Irini Sereti. 1. Clinical and Molecular Retrovirology Section, Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Abstract
PURPOSE OF REVIEW: HIV and pathogenic simian immunodeficiency virus infection are characterized by chronic immune activation. This review addresses the factors that influence immune activation and may thus determine the rate of disease progression during the asymptomatic period of HIV. RECENT FINDINGS: Immune activation stems from foreign antigen stimulation, including HIV, microbial products and coinfections and compensatory homeostatic mechanisms. Continuous immune stimulation creates a permissive environment for further viral replication, while temporarily allowing successful replenishment of the T-cell pool. Type I interferon, microbial translocation, activated (but ineffective) effector T cells, unruly regulatory T cells and inadequate T helper 17 cells all play important roles in the cycle of activation, functional exhaustion and T-cell death that leads to immunodeficiency. SUMMARY: The asymptomatic chronic phase of HIV infection is a dynamic balance between host and virus, the outcome of which determines an individual's course of disease. Evaluation of the factors that determine the immunologic threshold of disease progression could assist in designing therapeutic strategies, including individualized timing of ART.
PURPOSE OF REVIEW: HIV and pathogenic simian immunodeficiency virus infection are characterized by chronic immune activation. This review addresses the factors that influence immune activation and may thus determine the rate of disease progression during the asymptomatic period of HIV. RECENT FINDINGS: Immune activation stems from foreign antigen stimulation, including HIV, microbial products and coinfections and compensatory homeostatic mechanisms. Continuous immune stimulation creates a permissive environment for further viral replication, while temporarily allowing successful replenishment of the T-cell pool. Type I interferon, microbial translocation, activated (but ineffective) effector T cells, unruly regulatory T cells and inadequate T helper 17 cells all play important roles in the cycle of activation, functional exhaustion and T-cell death that leads to immunodeficiency. SUMMARY: The asymptomatic chronic phase of HIV infection is a dynamic balance between host and virus, the outcome of which determines an individual's course of disease. Evaluation of the factors that determine the immunologic threshold of disease progression could assist in designing therapeutic strategies, including individualized timing of ART.
Authors: Dimitrios I Zonios; Judith Falloon; John E Bennett; Pamela A Shaw; Doreen Chaitt; Michael W Baseler; Joseph W Adelsberger; Julia A Metcalf; Michael A Polis; Stephen B Kovacs; Stephen J Kovacs; Joseph A Kovacs; Richard T Davey; H Clifford Lane; Henry Masur; Irini Sereti Journal: Blood Date: 2008-05-02 Impact factor: 22.113
Authors: Nichole R Klatt; Francois Villinger; Pavel Bostik; Shari N Gordon; Lara Pereira; Jessica C Engram; Ann Mayne; Richard M Dunham; Benton Lawson; Sarah J Ratcliffe; Donald L Sodora; James Else; Keith Reimann; Silvija I Staprans; Ashley T Haase; Jacob D Estes; Guido Silvestri; Aftab A Ansari Journal: J Clin Invest Date: 2008-06 Impact factor: 14.808
Authors: Manuela Raffatellu; Renato L Santos; David E Verhoeven; Michael D George; R Paul Wilson; Sebastian E Winter; Ivan Godinez; Sumathi Sankaran; Tatiane A Paixao; Melita A Gordon; Jay K Kolls; Satya Dandekar; Andreas J Bäumler Journal: Nat Med Date: 2008-03-23 Impact factor: 53.440
Authors: Sunil K Ahuja; Hemant Kulkarni; Gabriel Catano; Brian K Agan; Jose F Camargo; Weijing He; Robert J O'Connell; Vincent C Marconi; Judith Delmar; Joseph Eron; Robert A Clark; Simon Frost; Jeffrey Martin; Seema S Ahuja; Steven G Deeks; Susan Little; Douglas Richman; Frederick M Hecht; Matthew J Dolan Journal: Nat Med Date: 2008-03-30 Impact factor: 53.440
Authors: Julien van Grevenynghe; Francesco A Procopio; Zhong He; Nicolas Chomont; Catherine Riou; Yuwei Zhang; Sylvain Gimmig; Genevieve Boucher; Peter Wilkinson; Yu Shi; Bader Yassine-Diab; Elias A Said; Lydie Trautmann; Mohamed El Far; Robert S Balderas; Mohamed-Rachid Boulassel; Jean-Pierre Routy; Elias K Haddad; Rafick-Pierre Sekaly Journal: Nat Med Date: 2008-03-02 Impact factor: 53.440
Authors: James Arthos; Claudia Cicala; Elena Martinelli; Katilyn Macleod; Donald Van Ryk; Danlan Wei; Zhen Xiao; Timothy D Veenstra; Thomas P Conrad; Richard A Lempicki; Sherry McLaughlin; Massimiliano Pascuccio; Ravindra Gopaul; Jonathan McNally; Catherine C Cruz; Nina Censoplano; Eva Chung; Kristin N Reitano; Shyam Kottilil; Diana J Goode; Anthony S Fauci Journal: Nat Immunol Date: 2008-02-10 Impact factor: 25.606
Authors: John C Tilton; Maura M Manion; Marlise R Luskin; Alison J Johnson; Andy A Patamawenu; Claire W Hallahan; Nancy A Cogliano-Shutta; Joann M Mican; Richard T Davey; Shyam Kottilil; Jeffrey D Lifson; Julia A Metcalf; Richard A Lempicki; Mark Connors Journal: J Virol Date: 2008-02-06 Impact factor: 5.103
Authors: Frank O Pettersen; Eirik A Torheim; Anders E A Dahm; Ingeborg S Aaberge; Andreas Lind; Malin Holm; Einar M Aandahl; Per M Sandset; Kjetil Taskén; Dag Kvale Journal: J Virol Date: 2011-04-13 Impact factor: 5.103
Authors: Jayme L Wiederin; Robert M Donahoe; James R Anderson; Fang Yu; Howard S Fox; Howard E Gendelman; Pawel S Ciborowski Journal: J Proteome Res Date: 2010-09-03 Impact factor: 4.466
Authors: Levelle D Harris; Brian Tabb; Donald L Sodora; Mirko Paiardini; Nichole R Klatt; Daniel C Douek; Guido Silvestri; Michaela Müller-Trutwin; Ivona Vasile-Pandrea; Cristian Apetrei; Vanessa Hirsch; Jeffrey Lifson; Jason M Brenchley; Jacob D Estes Journal: J Virol Date: 2010-05-19 Impact factor: 5.103
Authors: Andrea Lisco; Andrea Introini; Arshi Munawwar; Christophe Vanpouille; Jean-Charles Grivel; Paul Blank; Sarman Singh; Leonid Margolis Journal: Am J Reprod Immunol Date: 2012-09-24 Impact factor: 3.886
Authors: Joseph B Sempa; Jonathan Dushoff; Michael J Daniels; Barbara Castelnuovo; Agnes N Kiragga; Martin Nieuwoudt; Steven E Bellan Journal: Am J Epidemiol Date: 2016-05-04 Impact factor: 4.897
Authors: Andre Durudas; Jeffrey M Milush; Hui-Ling Chen; Jessica C Engram; Guido Silvestri; Donald L Sodora Journal: J Virol Date: 2009-09-16 Impact factor: 5.103